Enveda
Enveda uses AI to discover biologically active molecules from nature and develop them into small-molecule medicines for inflammatory and metabolic diseases.
$311MSeries E
ParticipantTR
T. Rowe Price Investment Management
Activity from announced rounds
All recorded activity
- Rounds participated in
- 6
- Confirmed lead rounds
- 1 4 roles undisclosed
- New companies
- 6 First participation on record · 0 follow-on
- Funding in participating rounds
- $2.3B 6 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
6 in all activityFORM ENERGY
Long-duration iron-air batteries designed to store electricity for multi-day grid needs.
$750MSeries G
LeadOllin Biosciences
Develops bispecific antibody therapies for retinal vascular diseases including diabetic macular edema and wet AMD
$330MSeries B
Role not disclosedSiFive
SiFive licenses RISC-V processor intellectual property for custom computing chips, including high-performance data-centre designs.
$400MSeries G
Role not disclosedCellares
Cellares manufactures cell therapies for drug developers using automated production and quality-control systems deployed through its Smart Factory network.
$257MSeries D
Role not disclosedMirador Therapeutics
Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases
$250MSeries B
Role not disclosed